FIELD: biotechnologies.
SUBSTANCE: invention proposes a method for quantitative determination of species composition of propionibacteria dwelling on human skin. The method provides for acquisition of a sample, extraction of RNA from it and performance of a quantitative PCR reaction. The reaction is performed with primers GCG TGA GTG ACG GTA ATG GGT A, TTC CGA CGC GAT CAA CCA, FAM-AGC GTT GTC CGG ATT TAT TGG GCG-BHQ1, ACA TGG ATC CGG GAG CTT C, ACC CAA CAT CTC ACG ACA CG, R6G-CGG TTC ACA GGT GGT GCA TTG GC-BHQ2, GTC TGC AAC TCG ACC CCA T, AGT CCT AAT TAC CAG TCC CAC, ROX-ACC TGT GTG GGG GAG CCG TCG AAG-BHQ2, AGA ACT CTG AGC GCT AGC TGT AG, CGT AGA ACT AGC TGT AGC GCA, Cy5-AG CGG CTC CTA CTT CTG CAG GGG-BHQ2.
EFFECT: method allows reducing time of investigations and performing a quantitative estimation of species composition of propionibacteria dwelling on human skin.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARATION OF WATER-SOLUBLE COMPONENT OF HUMAN RECEPTOR WITH LOW AFFINITY F @@@ | 0 |
|
SU1727533A3 |
ATTENUATED STRAIN OF SENDAI VIRUS | 2013 |
|
RU2552487C2 |
METHOD FOR OBTAINING A LINE OF HUMANIZED MICE CONTAINING 3974insT INSERTION IN THE mGrin2a GENE (MICE GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1), LEADING TO PREMATURE TERMINATION OF TRANSLATION OF THE grin2a PROTEIN | 2021 |
|
RU2764650C1 |
METHOD FOR ANALYSING DIFFERENTIALLY METHYLATED GENOMIC REGIONS IN BIOLOGICAL SAMPLES OF BONE MARROW AND BLOOD OF CHILDREN WITH ACUTE MYELOID LEUKAEMIA | 2017 |
|
RU2689727C2 |
APPLICATION OF A T5 PROMOTER FOR THE EXPRESSION OF THE GENE OF BETA-LYTIC PROTEASE LYSOBACTER CAPSICI VKM B-2533 AND STRAIN L. CAPSICI BLP P BEING PRODUCER OF SAID PROTEASE | 2021 |
|
RU2787787C1 |
METHOD OF OBTAINIG AN ATTENUATED PLASMID-FREE STRAIN OF F.TULARENSIS 15 CMSA, SYNTHESIZING MYCOBACTERIAL ANTIGEN SUPEROXIDE DISMUTASE A | 2019 |
|
RU2745161C1 |
METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
BIOSENSOR SYSTEM FOR FAST DETECTION OF DETERMINED COMPONENTS | 2016 |
|
RU2717658C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
RECOMBINANT PLASMID DNA CODING SYNTHESIS OF HUMAN SOMOTHROPIC HORMONE DERIVATIVES | 1983 |
|
RU1248280C |
Authors
Dates
2015-02-20—Published
2013-05-28—Filed